Skip to main content
padlock icon - secure page this page is secure

Assessing the Performance of 3D Pharmacophore Models in Virtual Screening: How Good are They?

Buy Article:

$68.00 + tax (Refund Policy)

Pharmacophore approaches have evolved to be one of the most successful tools in drug discovery, especially since the past two decades. 3D pharmacophore methods are now commonly used as part of more complex workflows in drug discovery campaigns, and have been successfully and extensively applied in virtual screening (VS) approaches. This review provides a perspective of how to assess the performance of 3D pharmacophore models to be used in VS. Since 3D VS protocols are in general assessed by their ability to discriminate between active and inactive compounds, we summarize the impact of the composition and preparation of modeling and external sets on the outcome of evaluations. Moreover, we highlight the significance of both classic enrichment parameters and advanced descriptors for the performance of 3D pharmacophore-based virtual screening methods.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Drug design; Enrichment descriptors; InhA; Performance evaluation; Pharmacophore model; Virtual screening

Document Type: Research Article

Publication date: May 1, 2013

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more